Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Origin Therapeutics Holdings, Inc. ( (TSE:SPLY) ).
Safe Supply Streaming Co Ltd. has sold two NIRLAB drug analysis devices to a First Nation community, expanding access to rapid, field-deployable substance identification technology in an area where lab infrastructure may be limited. The move aligns with the community’s proactive safety and resilience strategy, giving local leaders on-site tools to identify hazardous substances and strengthen health, safety, and emergency-response planning.
The transaction underscores growing demand for field-based drug-analysis solutions in Indigenous-led and remote settings, reinforcing Safe Supply’s positioning in public health–oriented technologies. Management indicated the company is pursuing further NIRLAB deployments with community organizations, institutional users, and government-aligned stakeholders, highlighting its focus on disciplined commercialization, responsible technology deployment, and long-term engagement.
More about Origin Therapeutics Holdings, Inc.
Safe Supply Streaming Co Ltd. is a publicly traded company operating at the intersection of public health and technology, focusing on innovations in healthcare, wellness, and emerging technologies. Through acquisitions, partnerships, and growth capital, it builds a diversified portfolio that leverages data, science, and digital platforms to improve access and outcomes at scale, supporting evidence-informed responses to urgent societal needs.
Average Trading Volume: 165,123
Technical Sentiment Signal: Sell
Current Market Cap: C$5.92M
Find detailed analytics on SPLY stock on TipRanks’ Stock Analysis page.